New antibody targets cancer fluid in lungs: early trial opens
Disease control
Recruiting now
This study tests a new drug called M701 in people with advanced lung cancer that has spread to the lining of the lungs, causing fluid buildup (malignant pleural effusion). The drug is a bispecific antibody designed to help the immune system attack cancer cells. The main goals are…
Phase: PHASE1, PHASE2 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:06 UTC